Diabetes and risk of adverse events with calcium antagonists.

Suppr

超能文献

作者信息

Pahor M, Kritchevsky S B, Zuccala G, Guralnik J M

出版信息

Diabetes Care. 1998 Jan;21(1):193-4. doi: 10.2337/diacare.21.1.193.

DOI:10.2337/diacare.21.1.193

PMID:9538995

Abstract

摘要

相似文献

Diabetes and risk of adverse events with calcium antagonists.

Diabetes Care. 1998 Jan;21(1):193-4. doi: 10.2337/diacare.21.1.193.

Diabetes and risk of adverse events with calcium antagonists.

Diabetes Care. 1998 Oct;21(10):1779-80. doi: 10.2337/diacare.21.10.1779.

Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.

Lancet. 1998 Jan 17;351(9097):216-7. doi: 10.1016/S0140-6736(05)78175-7.

Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.

Diabetes Care. 1999 Jul;22(7):1206-8. doi: 10.2337/diacare.22.7.1206.

Calcium antagonists, is there a real concern about safety?

Acta Clin Belg. 1998 Apr;53(2):61-5. doi: 10.1080/17843286.1998.11754144.

[Therapy of hypertension with calcium antagonists. Heart and kidney protection for elderly type 2 diabetic patients].

MMW Fortschr Med. 2000 Mar 16;142(11):18.

Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.

J Hum Hypertens. 1997 Jun;11(6):331-42. doi: 10.1038/sj.jhh.1000467.

Diabetes technology news. Calcium antagonists aid high blood pressure control.

Diabetes Technol Ther. 2003;5(3):510-1.

Hypertens Res. 1997 Jun;20(2):61-73.

Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.

Eur Heart J. 2000 Jan;21(1):2-7. doi: 10.1053/euhj.1999.1833.

引用本文的文献

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).

BMC Cardiovasc Disord. 2006 Oct 9;6:39. doi: 10.1186/1471-2261-6-39.

Evolution of calcium antagonists: past, present, and future.

Clin Cardiol. 2003 Feb;26(2 Suppl 2):II12-6. doi: 10.1002/clc.4960261405.

The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension.

Curr Cardiol Rep. 2001 Nov;3(6):511-8. doi: 10.1007/s11886-001-0074-1.

Controversies surrounding the treatment of the hypertensive patient with diabetes.

Curr Hypertens Rep. 1999 Dec;1(6):512-20. doi: 10.1007/s11906-996-0024-9.

Treatment of diabetic patients with hypertension.

Curr Hypertens Rep. 1999 Jun;1(3):225-31. doi: 10.1007/s11906-999-0025-6.

Antihypertensive drugs and diabetic nephropathy.

Curr Hypertens Rep. 1999 Apr-May;1(2):170-7. doi: 10.1007/s11906-999-0015-8.

Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.

Drugs Aging. 1998 Aug;13(2):99-108. doi: 10.2165/00002512-199813020-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验